A case of indolent systemic mastocytosis responding to treatment with Avapritinib
Key Clinical Message Low dose Avapritinib is a new medication that is a potential treatment option not just for advanced systemic mastocytosis, but also for the indolent form.
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-02-01
|
| Serier: | Clinical Case Reports |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/ccr3.8500 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|